Parkside Financial Bank & Trust’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-289
Closed -$6K 2072
2022
Q3
$6K Buy
289
+41
+17% +$854 ﹤0.01% 1185
2022
Q2
$5K Sell
248
-107
-30% -$1.9K ﹤0.01% 1283
2022
Q1
$6K Buy
355
+28
+9% +$489 ﹤0.01% 1258
2021
Q4
$7K Buy
327
+112
+52% +$2.11K ﹤0.01% 1199
2021
Q3
$4K Sell
215
-137
-39% -$3.14K ﹤0.01% 1390
2021
Q2
$9K Sell
352
-14
-4% -$392 ﹤0.01% 1024
2021
Q1
$11K Buy
366
+80
+28% +$2.73K ﹤0.01% 917
2020
Q4
$8K Buy
286
+71
+33% +$1.92K ﹤0.01% 961
2020
Q3
$5K Hold
215
﹤0.01% 953
2020
Q2
$4K Hold
215
﹤0.01% 1011
2020
Q1
$2K Buy
215
+147
+216% +$1.68K ﹤0.01% 1181
2019
Q4
$1K Buy
+68
New +$823 ﹤0.01% 1531
2019
Q2
Sell
-10
Closed 1703
2019
Q1
$0 Buy
+10
New +$355 ﹤0.01% 1680

Other funds holding CVET

Parkside Financial Bank & Trust's CVET Position: Q4 2022 in Review

Parkside Financial Bank & Trust sold out of Covetrus, Inc. Common Stock (CVET) in Q4 2022, closing a stake of 289 shares — an estimated $6K sold.

Parkside Financial Bank & Trust first reported a position in CVET in Q1 2019 and held it in 13 quarters. The position peaked at $11K in Q1 2021. 5 funds tracked by Wall St. Rank hold CVET as of Q4 2022.

  • Parkside Financial Bank & Trust reported no remaining Covetrus, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 289 Covetrus, Inc. Common Stock shares in Q4 2022, an estimated $6K.
  • Parkside Financial Bank & Trust first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and held it in 13 quarters.
  • Parkside Financial Bank & Trust's Covetrus, Inc. Common Stock position peaked at $11K in Q1 2021.
  • 5 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2022.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2022, filed 14 Feb 2023.